Spots Global Cancer Trial Database for cin3
Every month we try and update this database with for cin3 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | NCT05372016 | HPV Infections Cervical Cancer Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN3 VaIN1 VaIN2 VaIN3 Genital Wart VIN 1 VIN 2 VIN 3 AIS | Experimental: E... Active Comparat... | 16 Years - 26 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
| Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs) | NCT02554344 | Cervical Intrae... | Curcumin | 21 Years - | Baylor Research Institute | |
| Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia | NCT02139267 | Cervical Intrae... | GX-188E | 19 Years - 50 Years | Genexine, Inc. | |
| Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | NCT04425291 | Cervical Cancer Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN3 VaIN1 VaIN2 VaIN3 Genital Wart VIN 1 VIN 2 VIN 3 AIS | 4-valent HPV Va... 9-valent HPV Va... GARDASIL® | 20 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
| Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine | NCT05371353 | HPV Infections Cervical Cancer... Vaginal Cancer Genital Wart CIN1 CIN2 CIN3 | 9 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | ||
| A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females | NCT05584332 | Cervical Cancer Genital Wart CIN1 CIN2 CIN3 Vain I Vain III Vin I Vin II Vin III AIS VAIN - Vaginal ... | Quadrivalent Hu... Placebo | 18 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
| Cervical Cancer Screening With Human Papillomavirus Testing | NCT01881659 | CIN3 CIN2 Cervical Cancer | HPV screening | 30 Years - 64 Years | International Agency for Research on Cancer | |
| Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs) | NCT02554344 | Cervical Intrae... | Curcumin | 21 Years - | Baylor Research Institute | |
| Regression of Cervical Precancerous Lesions and Associated Risk Factors | NCT06147388 | Cervix Uteri SI... HPV CIN2 CIN3 | Colposcopy | 18 Years - 40 Years | General University Hospital, Prague | |
| Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years | NCT05027776 | HPV Infections Cervical Cancer... Vaginal Cancer Genital Wart CIN1 CIN2 CIN3 | 2-doses Group a... 3-doses Group a... 3-doses Group a... | 9 Years - 26 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
| Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia | NCT02139267 | Cervical Intrae... | GX-188E | 19 Years - 50 Years | Genexine, Inc. | |
| Urine HPV Testing for Cervical Cancer Screening Among Women Living With HIV in South Africa | NCT05413798 | Cervical Cancer CIN2 CIN3 | Urine HPV testi... Self-collected ... Provider-collec... | 25 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia | NCT02139267 | Cervical Intrae... | GX-188E | 19 Years - 50 Years | Genexine, Inc. | |
| Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV | NCT05413811 | Cervical Cancer CIN2 CIN3 Human Immunodef... Human Papilloma... | 5 Fluorouracil ... Placebo | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | NCT05372016 | HPV Infections Cervical Cancer Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN3 VaIN1 VaIN2 VaIN3 Genital Wart VIN 1 VIN 2 VIN 3 AIS | Experimental: E... Active Comparat... | 16 Years - 26 Years | Shanghai Bovax Biotechnology Co., Ltd. | |
| Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | NCT04422366 | Cervical Cancer Vulvar Cancer Vaginal Cancer CIN1 CIN2 CIN3 VaIN1 VaIN2 VaIN3 Genital Wart VIN 1 VIN 2 VIN 3 AIS | 9-valent Human ... GARDASIL® | 20 Years - 45 Years | Shanghai Bovax Biotechnology Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
